Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
15 October 2025
| Name: | REWARDLE HOLDINGS LIMITED (RXH) |
| ISIN: | AU000000RXH4 |
| Date of Listing: | 07 October 2014 |
| Date of Delisting: | 02 October 2025 |
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 02 October 2025.Legal Status:
ACN: 168 751 746ABN: 37 168 751 746
Registration Date: 25 March 2014
Capital Gains Tax (CGT) Status:
The securities in this entity, in our opinion, are of little or no value. We have made that assessment by reference to the circumstances leading to a suspension and/or delisting, the length of a suspension, share trading history and last on-market share price, most recent financial and cash flow statements, prospects (including likelihood of re-financing), and other factors including in particular whether the entity is in external administration. If you are seeking to crystallise a capital loss on your securities, that process can be easily and quickly initiated at our online Worthless Shares facility here: https://www.delisted.com.au/sell-worthless-and-other-securities/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
REGISTRY:
Automic Group
Level 5, 126 Philip Street Sydney NSW 2000
GPO Box 5193 Sydney NSW 2001
Tel : 1300 288 664 or +61 2 9698 5414
Fax : +61 2 8583 3040
RegistryWebsite RegistryEmail
Shareholders in this company should consider crystallising a capital loss in 2025/26 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person. | 03/10/2025 |
delisted by ASX under Listing Rule 17.12 | 02/10/2025 |
we understand the company was delisted because its securities have been suspended from trading for a continuous period of more than 2 years | 02/10/2025 |
The company's securities will be removed from ASX on 3 October 2025 due to non-compliance with listing rules. The Board remains committed to operational growth as an unlisted public company and seeks potential listing on NSX. | 01/10/2025 |
The securities of Rewardle Holdings Limited were suspended from quotation under Listing Rule 17.5 on 2 October 2023 due to the failure to lodge annual audited financial statements for the year ended 30 June 2023. The suspension will remain in effect under Listing Rule 17.3 as RXH is not compliant with Listing Rules 12.5 and 12.2. ASX has referenced several communications and financial documents in making this determination. RXH's securities will remain suspended until compliance is achieved, with a potential removal from the Official List set for 3 October 2025, two years after the suspension commenced. | 26/09/2025 |
The company releases a response to an ASX aware query. | 24/09/2025 |
The company has established a Standby Debt Facility Agreement with Temorex Pty Ltd, allowing for a revolving standby debt facility of AUD $2,000,000. The 12-month facility aims to provide working capital at an interest rate of 12% per annum on drawn amounts. Key fees include a $25,000 establishment fee and a 1.5% annual facility fee, payable in monthly installments. The minimum drawdown is $250,000, with repayments due within 12 months post-term. The facility is secured by a Specific Security Deed over shares in CloudHolter Pty Ltd owned by Rewardle. | 24/09/2025 |
The company lodges its appendix 4G. | 23/09/2025 |
The company has acquired a 49.9% stake in CloudHolter for $24.85 million. CloudHolter, which is developing an AI-powered ECG analysis solution, recently secured $4.75 million in convertible debt at a $100 million pre-money valuation, bringing its total convertible note funding to $14 million. These notes are set to convert to shares by December 31, 2025, or June 30, 2026. The company continues to provide Growth Services to CloudHolter, earning fees and expressing confidence in its growth and future fundraising. | 17/09/2025 |
The company releases its annual report for year ended 2025. | 15/09/2025 |
The company releases its response to an ASX aware query. | 09/09/2025 |
The company lodges its chairman's update and appendix 4E for June 2025. | 08/09/2025 |
The company lodges its half-year report and appendix 4D for December 2024. | 29/08/2025 |
The company lodges its appendix 4E, appendix 4G, and its annual report for June 2024. | 08/08/2025 |
The company releases its quarterly activities and appendix 4C cash flow report. | 30/07/2025 |
The company has been suspended from trading due to failing to lodge Full Year Accounts for the period ended 30 June 2023. ASX has scheduled RXH's removal from the official list on 30 August 2025 unless it lodges its Preliminary Final Report for the year ended 30 June 2024. | 25/07/2025 |
Entities with securities suspended for over three months must lodge periodic reports, meet a 1 year deadline for the oldest outstanding report, and execute plans for resuming trading to ASX's satisfaction. Failure to meet deadlines results in removal from the official list. | 16/07/2025 |
The company releases its response to an ASX aware query. | 09/07/2025 |
Entities that have been suspended for more than three months due to their unfiled periodic reports, along with the oldest overdue report deadline and their two-year deadline for trading plans, will be removed from the official list if these conditions are not fulfilled. | 09/04/2025 |
The company lodges its Half Yearly Report and Accounts from December 2023. | 19/02/2025 |
The company releases a response to an ASX query letter. | 12/02/2025 |
The company lodges its Quarterly Activities and Quarterly Appendix 4C Cash Flow Report. | 31/01/2025 |
The entities suspended for over three months failed periodic reports, the oldest outstanding report deadline, and their 2 year deadline for trading plans. If not met, they will be removed from the official list, usually after the first trading day. | 22/01/2025 |
The company will release 2,600,000 fully paid ordinary shares from voluntary escrow on 26 December 2024, in connection with the acquisition of 100% of Sub11 Pty Ltd shares. | 19/12/2024 |
The company lodges its Quarterly Activities Report. | 31/10/2024 |
The company lodges its Quarterly Appendix 4C Cash Flow Report. | 31/10/2024 |
ASX releases a notice regarding long-term suspended entities. The company's securities have been suspended for more than 3 months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date. | 18/10/2024 |
The company has suspended trading in its listed securities due to inability to lodge the FY23 accounts by 29th September 2023. The suspension will continue until the outstanding accounts are settled. The company has released its Audited FY23 Annual Report, which will aid in preparing the interim and preliminary reports. The company is working with its auditor to complete outstanding accounts. | 02/09/2024 |
The company lodges its appendix 4g. | 02/09/2024 |
The company lodges its annual report to shareholders for 2023. | 30/08/2024 |
The company lodges its Quarterly Appendix 4C Cash Flow Report and Quarterly Activities Report. | 01/08/2024 |
The securities of the company have been suspended for more than three months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date. | 10/07/2024 |
The Company is currently working with its auditor to complete the audit of the Company's FY23 Annual Report, which in turn facilitates the opening balances to be used in preparation of the Company's outstanding 31 December 2023 Interim Report. While it was initially expected that the audit and audit review of the outstanding accounts could be completed prior to 30 June 2024, the work is ongoing. The Company is working with its auditor to complete the audit and audit review of the outstanding accounts as soon as practicable and will provide further updates as appropriate. | 01/07/2024 |
The company releases an update on trading suspension. The Company was unable to lodge its FY23 accounts by 29th September 2023, leading to suspended trading in its listed securities. The delay was due to auditors determining audited accounts were required for CloudHolter Pty Ltd, a private company not controlled by the Company. The Company requested CH to undertake an audit and work with CH and its auditors. However, CH had strategic and technical considerations to work through. The Company is now working with CH to schedule the completion of the audit and audit review of outstanding accounts, with the outstanding accounts expected to be lodged before 30 June 2024. The Company is working with auditors to schedule the audit and review of outstanding accounts as soon as possible. | 03/05/2024 |
The company releases its Quarterly Appendix 4C Cash Flow Report. | 30/04/2024 |
The company releases its Quarterly Activities Report. | 30/04/2024 |
The company lodges its Appendix 4C Cash Flow Report. | 01/02/2024 |
The company lodges its Quarterly Activities Report. | 01/02/2024 |
The company releases a notice of application for quotation of securities. | 19/12/2023 |
The company releases a notice of proposed issue of securities. | 18/12/2023 |
Acquisition of Sub11, a Fintech sector publisher and investor engagement consultancy. Sub11 will leverage Rewardle's recent acquisition of the distribution rights to the Upstreet fund. Sub11 valuation of ~$75,000 to be paid via issue of 2,600,000 RXH Fully Paid Ordinary Shares. | 18/12/2023 |
$1.5m investment to acquire controlling stake in meal kit partner Pepper Leaf. Majority of investment retained as working capital via commercialloan arrangement. Consolidates grocery volume and expands grocery service offering. | 08/11/2023 |
The company lodges its Quarterly Activities Report. | 01/11/2023 |
The company lodges its Appendix 4C Cash Flow Report. | 01/11/2023 |
Rewardle has completed the acquisition of the distribution rights for the Upstreetfund for $30,000 (once off) and ~$15,000/month (ongoing operating cost), which will provide the Rewardle Platform with micro-investing capability. The transaction substantially reduces the cost and accelerates the speed to market of extending the Rewardle Platform to include micro-investing capability. Initial implementation expected to be live in the next 2-3 weeks withphased releases of additional features and functionality to follow in coming months. | 10/10/2023 |
The securities of the entity will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Monday, 2 October 2023, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Friday, 29 September 2023, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 02/10/2023 |
The suspension of trading in the securities of Rewardle Holdings Limited will be lifted from the commencement of trading on Tuesday, 2 May 2023 following lodgement of its quarterly activity report and Appendix 4C for the quarter ended 31 March 2023. | 02/05/2023 |
The securities of the entity will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Monday, 1 May 2023, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Friday, 28 April 2023, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 01/05/2023 |
The company lodges its Quarterly Activities Report. | 01/05/2023 |
The company lodges its Appendix 4C Cash Flow Report. | 01/05/2023 |
The suspension of trading in the securities of Rewardle Holdings Limited will be lifted immediately, following the release by RXH of an announcement regarding a further announcement in relation to the application of Listing Rule 11.1 to the transaction, the subject of the announcement released on 2 August 2021, titled "MedTech Growth Services Agreement". | 12/08/2021 |
Listing Rule 11.1 does not apply to the Transaction which included the execution of a binding Terms Sheet to provide services to Cardiac Rhythm Diagnostics, a fast-growing MedTech business that is developing a disruptive, technology enabled cardiac diagnostics service for local GPs. | 12/08/2021 |
The securities of Rewardle Holdings Limited will be suspended from quotation from the commencement of trading on Friday, 6 August 2021 under Listing under Listing Rule 17.2, at the request of RXH, pending the release of a further announcement in relation to the application of Listing Rule 11.1 to the transaction, the subject of the announcement released on 2 August 2021, titled "MedTech Growth Services Agreement". | 06/08/2021 |
The suspension of trading in the securities of Rewardle Holdings Limited (the "Company ") will be lifted immediately, following receipt of an announcement regarding a capital raising of $5 million. Security Code: RXH | 27/03/2015 |
The securities of Rewardle Holdings Limited (the "Company") will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement. Security Code: RXH | 26/03/2015 |
Shareholders in this company should consider crystallising a capital loss in 2025/26 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person. | 03/10/2025 |
delisted by ASX under Listing Rule 17.12 | 02/10/2025 |
we understand the company was delisted because its securities have been suspended from trading for a continuous period of more than 2 years | 02/10/2025 |
The company's securities will be removed from ASX on 3 October 2025 due to non-compliance with listing rules. The Board remains committed to operational growth as an unlisted public company and seeks potential listing on NSX. | 01/10/2025 |
The securities of Rewardle Holdings Limited were suspended from quotation under Listing Rule 17.5 on 2 October 2023 due to the failure to lodge annual audited financial statements for the year ended 30 June 2023. The suspension will remain in effect under Listing Rule 17.3 as RXH is not compliant with Listing Rules 12.5 and 12.2. ASX has referenced several communications and financial documents in making this determination. RXH's securities will remain suspended until compliance is achieved, with a potential removal from the Official List set for 3 October 2025, two years after the suspension commenced. | 26/09/2025 |
The company releases a response to an ASX aware query. | 24/09/2025 |
The company has established a Standby Debt Facility Agreement with Temorex Pty Ltd, allowing for a revolving standby debt facility of AUD $2,000,000. The 12-month facility aims to provide working capital at an interest rate of 12% per annum on drawn amounts. Key fees include a $25,000 establishment fee and a 1.5% annual facility fee, payable in monthly installments. The minimum drawdown is $250,000, with repayments due within 12 months post-term. The facility is secured by a Specific Security Deed over shares in CloudHolter Pty Ltd owned by Rewardle. | 24/09/2025 |
The company lodges its appendix 4G. | 23/09/2025 |
The company has acquired a 49.9% stake in CloudHolter for $24.85 million. CloudHolter, which is developing an AI-powered ECG analysis solution, recently secured $4.75 million in convertible debt at a $100 million pre-money valuation, bringing its total convertible note funding to $14 million. These notes are set to convert to shares by December 31, 2025, or June 30, 2026. The company continues to provide Growth Services to CloudHolter, earning fees and expressing confidence in its growth and future fundraising. | 17/09/2025 |
The company releases its annual report for year ended 2025. | 15/09/2025 |
The company releases its response to an ASX aware query. | 09/09/2025 |
The company lodges its chairman's update and appendix 4E for June 2025. | 08/09/2025 |
The company lodges its half-year report and appendix 4D for December 2024. | 29/08/2025 |
The company lodges its appendix 4E, appendix 4G, and its annual report for June 2024. | 08/08/2025 |
The company releases its quarterly activities and appendix 4C cash flow report. | 30/07/2025 |
The company has been suspended from trading due to failing to lodge Full Year Accounts for the period ended 30 June 2023. ASX has scheduled RXH's removal from the official list on 30 August 2025 unless it lodges its Preliminary Final Report for the year ended 30 June 2024. | 25/07/2025 |
Entities with securities suspended for over three months must lodge periodic reports, meet a 1 year deadline for the oldest outstanding report, and execute plans for resuming trading to ASX's satisfaction. Failure to meet deadlines results in removal from the official list. | 16/07/2025 |
The company releases its response to an ASX aware query. | 09/07/2025 |
Entities that have been suspended for more than three months due to their unfiled periodic reports, along with the oldest overdue report deadline and their two-year deadline for trading plans, will be removed from the official list if these conditions are not fulfilled. | 09/04/2025 |
The company lodges its Half Yearly Report and Accounts from December 2023. | 19/02/2025 |
The company releases a response to an ASX query letter. | 12/02/2025 |
The company lodges its Quarterly Activities and Quarterly Appendix 4C Cash Flow Report. | 31/01/2025 |
The entities suspended for over three months failed periodic reports, the oldest outstanding report deadline, and their 2 year deadline for trading plans. If not met, they will be removed from the official list, usually after the first trading day. | 22/01/2025 |
The company will release 2,600,000 fully paid ordinary shares from voluntary escrow on 26 December 2024, in connection with the acquisition of 100% of Sub11 Pty Ltd shares. | 19/12/2024 |
The company lodges its Quarterly Activities Report. | 31/10/2024 |
The company lodges its Quarterly Appendix 4C Cash Flow Report. | 31/10/2024 |
ASX releases a notice regarding long-term suspended entities. The company's securities have been suspended for more than 3 months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date. | 18/10/2024 |
The company has suspended trading in its listed securities due to inability to lodge the FY23 accounts by 29th September 2023. The suspension will continue until the outstanding accounts are settled. The company has released its Audited FY23 Annual Report, which will aid in preparing the interim and preliminary reports. The company is working with its auditor to complete outstanding accounts. | 02/09/2024 |
The company lodges its appendix 4g. | 02/09/2024 |
The company lodges its annual report to shareholders for 2023. | 30/08/2024 |
The company lodges its Quarterly Appendix 4C Cash Flow Report and Quarterly Activities Report. | 01/08/2024 |
The securities of the company have been suspended for more than three months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date. | 10/07/2024 |
The Company is currently working with its auditor to complete the audit of the Company's FY23 Annual Report, which in turn facilitates the opening balances to be used in preparation of the Company's outstanding 31 December 2023 Interim Report. While it was initially expected that the audit and audit review of the outstanding accounts could be completed prior to 30 June 2024, the work is ongoing. The Company is working with its auditor to complete the audit and audit review of the outstanding accounts as soon as practicable and will provide further updates as appropriate. | 01/07/2024 |
The company releases an update on trading suspension. The Company was unable to lodge its FY23 accounts by 29th September 2023, leading to suspended trading in its listed securities. The delay was due to auditors determining audited accounts were required for CloudHolter Pty Ltd, a private company not controlled by the Company. The Company requested CH to undertake an audit and work with CH and its auditors. However, CH had strategic and technical considerations to work through. The Company is now working with CH to schedule the completion of the audit and audit review of outstanding accounts, with the outstanding accounts expected to be lodged before 30 June 2024. The Company is working with auditors to schedule the audit and review of outstanding accounts as soon as possible. | 03/05/2024 |
The company releases its Quarterly Appendix 4C Cash Flow Report. | 30/04/2024 |
The company releases its Quarterly Activities Report. | 30/04/2024 |
The company lodges its Appendix 4C Cash Flow Report. | 01/02/2024 |
The company lodges its Quarterly Activities Report. | 01/02/2024 |
The company releases a notice of application for quotation of securities. | 19/12/2023 |
The company releases a notice of proposed issue of securities. | 18/12/2023 |
Acquisition of Sub11, a Fintech sector publisher and investor engagement consultancy. Sub11 will leverage Rewardle's recent acquisition of the distribution rights to the Upstreet fund. Sub11 valuation of ~$75,000 to be paid via issue of 2,600,000 RXH Fully Paid Ordinary Shares. | 18/12/2023 |
$1.5m investment to acquire controlling stake in meal kit partner Pepper Leaf. Majority of investment retained as working capital via commercialloan arrangement. Consolidates grocery volume and expands grocery service offering. | 08/11/2023 |
The company lodges its Quarterly Activities Report. | 01/11/2023 |
The company lodges its Appendix 4C Cash Flow Report. | 01/11/2023 |
Rewardle has completed the acquisition of the distribution rights for the Upstreetfund for $30,000 (once off) and ~$15,000/month (ongoing operating cost), which will provide the Rewardle Platform with micro-investing capability. The transaction substantially reduces the cost and accelerates the speed to market of extending the Rewardle Platform to include micro-investing capability. Initial implementation expected to be live in the next 2-3 weeks withphased releases of additional features and functionality to follow in coming months. | 10/10/2023 |
The securities of the entity will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Monday, 2 October 2023, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Friday, 29 September 2023, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 02/10/2023 |
The suspension of trading in the securities of Rewardle Holdings Limited will be lifted from the commencement of trading on Tuesday, 2 May 2023 following lodgement of its quarterly activity report and Appendix 4C for the quarter ended 31 March 2023. | 02/05/2023 |
The securities of the entity will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Monday, 1 May 2023, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Friday, 28 April 2023, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 01/05/2023 |
The company lodges its Quarterly Activities Report. | 01/05/2023 |
The company lodges its Appendix 4C Cash Flow Report. | 01/05/2023 |
The suspension of trading in the securities of Rewardle Holdings Limited will be lifted immediately, following the release by RXH of an announcement regarding a further announcement in relation to the application of Listing Rule 11.1 to the transaction, the subject of the announcement released on 2 August 2021, titled "MedTech Growth Services Agreement". | 12/08/2021 |
Listing Rule 11.1 does not apply to the Transaction which included the execution of a binding Terms Sheet to provide services to Cardiac Rhythm Diagnostics, a fast-growing MedTech business that is developing a disruptive, technology enabled cardiac diagnostics service for local GPs. | 12/08/2021 |
The securities of Rewardle Holdings Limited will be suspended from quotation from the commencement of trading on Friday, 6 August 2021 under Listing under Listing Rule 17.2, at the request of RXH, pending the release of a further announcement in relation to the application of Listing Rule 11.1 to the transaction, the subject of the announcement released on 2 August 2021, titled "MedTech Growth Services Agreement". | 06/08/2021 |
The suspension of trading in the securities of Rewardle Holdings Limited (the "Company ") will be lifted immediately, following receipt of an announcement regarding a capital raising of $5 million. Security Code: RXH | 27/03/2015 |
The securities of Rewardle Holdings Limited (the "Company") will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement. Security Code: RXH | 26/03/2015 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 15/05/2023 | Ruwan Weerasooriya | 364,667 | $0.034 | $12,399 | |
| 15/05/2023 | Rodney House | 267,033 | $0.037 | $9,866 | |
| 09/05/2023 | Rodney House | 298,572 | $0.034 | $10,000 | |
| 09/05/2023 | Ruwan Weerasooriya | 431,500 | $0.033 | $14,126 | |
| 09/05/2023 | David Niall | 720,000 | $0.033 | $23,700 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Ruwan Weerasooriya | Executive Chairman, Managing Director | 07/10/2014 |
| Nicholas Day | CFO, Company Secretary | |
| Rodney House | Non Exec Director | 03/01/2019 |
| David Niall | Executive Director | 30/05/2017 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Peter Pawlowitsch | Independent Director | 30/05/2017 | 03/01/2019 |
| Jack Matthews | Non Exec Chairman | 07/10/2014 | 30/05/2017 |
| Brandon Munro | Non Exec Director | 07/10/2014 | 30/05/2017 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
